Clinical Trial Update: Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients [NA]

View source ↗

Summary

This completed clinical trial compares mean hemoglobin change in anemic antenatal patients treated with ferric carboxymaltose versus intravenous iron sucrose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)
• Iron sucrose (iron sucrose)

Snippet

Sponsor: Muhammad Aamir Latif | Conditions: Anemia | NA | Status: COMPLETED